Zura Bio Ltd (ZURA)
Data as of , from SEC Form 4 filings.
See up to 3 months of ZURA. The 7-day demo opens the 1M and 3M ranges and puts ZURA on your watchlist.
Start 7-day demoLatest ZURA insider trades
- AI Biotechnology LLCOpen-market purchase$12.50M
- Parvinder ThiaraOpen-market sale$2.73M
Jennifer JarrettGrant or award
About Zura Bio Ltd (ZURA)
The SEC lists Zura Bio Ltd under CIK 0001855644, in biological products (no diagnostic substances). We track it alongside the rest of the Health Care sector.
ZURA Form 4 activity by transaction type, last 90 days
No Form 4 activity for ZURA in the last 90 days.
ZURA insider transactions (Form 4)
3029 Form 4 filings on record, the earliest from Nov 27, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jennifer Jarrett | Grant or award | Share Option (Right to Buy) | 51,000 | $0.00 | - | |
| Parvinder Thiara | Grant or award | Share Option (Right to Buy) | 51,000 | $0.00 | - | |
| Steven J. Schoch | Grant or award | Share Option (Right to Buy) | 51,000 | $0.00 | - | |
 Ajay Nirula | Grant or award | Share Option (Right to Buy) | 51,000 | $0.00 | - | |
| Amit Munshi | Grant or award | Share Option (Right to Buy) | 51,000 | $0.00 | - | |
| Mark Eisner | Grant or award | Share Option (Right to Buy) | 51,000 | $0.00 | - | |
| Daniel J. Becker | Grant or award | Share Option (Right to Buy) | 51,000 | $0.00 | - | |
| Gary Whale - Officer | Grant or award | Employee Share Option (Right to Buy) | 263,000 | $0.00 | - | |
| Kiran Nistala - Officer | Grant or award | Employee Share Option (Right to Buy) | 340,900 | $0.00 | - | |
| Eric J. Hyllengren - Officer | Grant or award | Employee Share Option (Right to Buy) | 340,900 | $0.00 | - | |
| Kim Davis - Officer | Grant or award | Employee Share Option (Right to Buy) | 425,700 | $0.00 | - | |
| Sandeep Chidambar Kulkarni - Officer | Grant or award | Employee Share Option (Right to Buy) | 894,000 | $0.00 | - | |
| Ajay Nirula | Grant or award | Share Option (Right to Buy) | 37,812 | $0.00 | - | |
| AI Biotechnology LLC | Open-market purchase | Class A Ordinary Shares | 2,000,000 footnote F1 | $6.25 | $12.50M | |
| ||||||
| Mark Eisner | Grant or award | Share Option (Right to Buy) | 37,812 | $0.00 | - | |
| Parvinder Thiara | Grant or award | Share Option (Right to Buy) | 38,823 | $0.00 | - | |
| Sandeep Chidambar Kulkarni - Officer | Grant or award | Employee Share Option (Right to Buy) | 2,934,107 | $0.00 | - | |
| Eric J. Hyllengren - Officer | Grant or award | Employee Share Option (Right to Buy) | 672,000 | $0.00 | - | |
| Kim Davis - Officer | Grant or award | Class A Ordinary Shares | 500 | $0.00 | - | |
| Kim Davis - Officer | Grant or award | Class A Ordinary Shares | 1,000 | $0.00 | - | |
| Neil Murray Hamilton Graham | Grant or award | Share Option (Right to Buy) | 117,000 | $0.00 | - | |
| van Amstel Arnout Ploos | Grant or award | Share Option (Right to Buy) | 117,000 | $0.00 | - | |
| Steven J. Schoch | Grant or award | Share Option (Right to Buy) | 117,000 | $0.00 | - | |
| Sandeep Chidambar Kulkarni | Grant or award | Share Option (Right to Buy) | 117,000 | $0.00 | - | |
| Parvinder Thiara | Grant or award | Share Option (Right to Buy) | 117,000 | $0.00 | - | |
| Someit Sidhu | Grant or award | Share Option (Right to Buy) | 117,000 | $0.00 | - | |
| Robert Lisicki - Officer | Grant or award | Employee Share Option (Right to Buy) | 117,000 | $0.00 | - | |
| Jennifer Jarrett | Grant or award | Share Option (Right to Buy) | 117,000 | $0.00 | - | |
| Amit Munshi | Grant or award | Share Option (Right to Buy) | 117,000 | $0.00 | - | |
| Parvinder Thiara | Open-market sale | Class A Ordinary Shares | 1,001,633 | $2.73 | $2.73M | |
Recent ZURA Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| SOMEIT SIDHU | Director | 50,000 | $288K | View on EDGAR | |
| SOMEIT SIDHU | Director | 27,000 | $151K |
ZURA insider trading FAQ
What is the latest insider trade for ZURA?
Zura Bio Ltd (ZURA) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-06-22. The full record for ZURA runs to 29 Form 4 filings, the earliest from 2024-11-27. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying ZURA stock?
No insider purchases of ZURA were filed in the last 90 days. 1 purchase is on record for this company.
How many insiders are selling ZURA stock?
No insider sales of ZURA were filed in the last 90 days. 1 sale is on record for this company.
Where can I see ZURA SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects ZURA Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Jennifer Jarrett view on EDGAR
- - Parvinder Thiara view on EDGAR
- - Steven J. Schoch view on EDGAR
- - Ajay Nirula view on EDGAR
- - Amit Munshi view on EDGAR
- - Mark Eisner view on EDGAR
- - Daniel J. Becker view on EDGAR
- - Gary Whale view on EDGAR
- - Kiran Nistala view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where ZURA's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow ZURA with a 7-day demo
- ZURA on your watchlist
- Every ZURA Form 4 filing on record
- Up to 3 months of ZURA price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
